Get key Q3 2025 earnings call insights on Cytosorbents (CTSO): growth drivers, FDA progress, cost controls, and outlook.
The resignation of KPMG LLP was accepted, and the appointment of PwC was approved by the Board of Directors of the Company upon the recommendation of the Audit Committee. There has not been any ...
Dynacor Group Inc. (TSX: DNG) (“Dynacor” or the “Corporation”) today announced its unaudited financial and operational results 1 for the third quarter ended September 30, 2025. “This was a solid third ...
Revenue for the quarter ended September 30, 2025, is $295.3 millionNet income for the quarter ended September 30, 2025, is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback